Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Characteristics of patients responding and not responding to nivolumab treatment according to iPERCIST
| iPERCIST responders (n = 19) | iPERCIST non-responders (n = 9) | p value | |
|---|---|---|---|
| Male (%) | 13 (68) | 4 (44) | 0.6775 |
| Tobacco use (%) | 16 (84) | 7 (78) | 0.99 |
| Age (mean, range), years | 64 (42–79) | 58 (50–79) | 0.22 |
| Adenocarcinoma (%) | 14 (74) | 7 (78) | 0.99 |
| Lines of chemotherapy before nivolumab (mean, range) | 1.8 (1–5) | 2.0 (1–5) | 0.35 |
| Survival (months, median) | 19.9 | 3.6 | < 0.0001 |
